Mouth breathing, another risk factor for asthma: the Nagahama Study

Background Allergic rhinitis, a known risk factor for asthma onset, often accompanies mouth breathing. Mouth breathing may bypass the protective function of the nose and is anecdotally considered to increase asthma morbidity. However, there is no epidemiological evidence that mouth breathing is inde...

Full description

Saved in:
Bibliographic Details
Published in:Allergy (Copenhagen) Vol. 71; no. 7; pp. 1031 - 1036
Main Authors: Izuhara, Y., Matsumoto, H., Nagasaki, T., Kanemitsu, Y., Murase, K., Ito, I., Oguma, T., Muro, S., Asai, K., Tabara, Y., Takahashi, K., Bessho, K., Sekine, A., Kosugi, S., Yamada, R., Nakayama, T., Matsuda, F., Niimi, A., Chin, K., Mishima, M.
Format: Journal Article
Language:English
Published: Denmark Blackwell Publishing Ltd 01-07-2016
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Allergic rhinitis, a known risk factor for asthma onset, often accompanies mouth breathing. Mouth breathing may bypass the protective function of the nose and is anecdotally considered to increase asthma morbidity. However, there is no epidemiological evidence that mouth breathing is independently associated with asthma morbidity and sensitization to allergens. In this study, we aimed to clarify the association between mouth breathing and asthma morbidity and allergic/eosinophilic inflammation, while considering the effect of allergic rhinitis. Methods This community‐based cohort study, the Nagahama Study, contained a self‐reporting questionnaire on mouth breathing and medical history, blood tests, and pulmonary function testing. We enrolled 9804 general citizens of Nagahama City in the Shiga Prefecture, Japan. Results Mouth breathing was reported by 17% of the population and was independently associated with asthma morbidity. The odds ratio for asthma morbidity was 1.85 (95% CI, 1.27–2.62) and 2.20 (95% CI, 1.72–2.80) in subjects with mouth breathing alone and allergic rhinitis alone, which additively increased to 4.09 (95% CI, 3.01–5.52) when mouth breathing and allergic rhinitis coexisted. Mouth breathing in nonasthmatics was a risk for house dust mite sensitization, higher blood eosinophil counts, and lower pulmonary function after adjusting for allergic rhinitis. Conclusion Mouth breathing may increase asthma morbidity, potentially through increased sensitization to inhaled allergens, which highlights the risk of mouth‐bypass breathing in the ‘one airway, one disease’ concept. The risk of mouth breathing should be well recognized in subjects with allergic rhinitis and in the general population.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0105-4538
1398-9995
DOI:10.1111/all.12885